Mehrdad Shamloo
Affiliations: | Stanford University, Palo Alto, CA |
Area:
NeurosurgeryGoogle:
"Mehrdad Shamloo"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu Q, Johnson EM, Lam RK, et al. (2019) Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity. Nature Immunology |
| Liu Q, Liang X, Wang Q, et al. (2019) PGE signaling via the neuronal EP2 receptor increases injury in a model of cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America |
| Ravina K, Briggs DI, Kislal S, et al. (2018) Intracerebral Delivery of Brain-Derived Neurotrophic Factor Using HyStem-C Hydrogel Implants Improves Functional Recovery and Reduces Neuroinflammation in a Rat Model of Ischemic Stroke. International Journal of Molecular Sciences. 19 |
| Huang WH, Wang DC, Allen WE, et al. (2018) Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome. Proceedings of the National Academy of Sciences of the United States of America |
| Djurisic M, Brott BK, Saw NL, et al. (2018) Activity-dependent modulation of hippocampal synaptic plasticity via PirB and endocannabinoids. Molecular Psychiatry |
| Joshi AU, Saw NL, Shamloo M, et al. (2018) Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease. Oncotarget. 9: 6128-6143 |
| Joshi AU, Saw NL, Vogel H, et al. (2018) Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. Embo Molecular Medicine |
| Yi B, Jahangir A, Evans AK, et al. (2017) Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders. Plos One. 12: e0180319 |
| Ardestani PM, Evans AK, Yi B, et al. (2017) Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist. Neuropharmacology |
| Simmons DA, Belichenko NP, Ford EC, et al. (2016) A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice. Human Molecular Genetics. 25: 4920-4938 |